New Market Research Report: Digestive Remedies in Belgium
Digestive remedies experienced conflicting factors in 2012. After the positive switch of ranitidine in H2 blockers in 2009, after years of waiting, the first proton pump inhibitors were able to enter the Belgian market from the end of 2011, notably thanks to Maalox Control (pantoprazole-based) and Sandoz's Acidcare (omeprazole-based). On the other hand, the category bore the brunt of the sudden questioning of Janssen-Cilag's Motilium, the leading brand in digestive remedies.
View full press release